Paul Tudor Jones's CLPT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 156,971 shares of ClearPoint Neuro, Inc. (CLPT) worth $1.43 M, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in CLPT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 156,971 shares. Largest reduction occurred in Q2 2025, reducing 104,381 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's ClearPoint Neuro (CLPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly ClearPoint Neuro (CLPT) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +156,971 | New Buy | 156,971 | $9.10 |
| Q3 2025 | -24,317 | Sold Out | 0 | $0.00 |
| Q2 2025 | -104,381 | Reduce 81.11% | 24,317 | $11.94 |
| Q1 2025 | +128,698 | New Buy | 128,698 | $11.89 |
Paul Tudor Jones's ClearPoint Neuro Investment FAQs
Paul Tudor Jones first purchased ClearPoint Neuro, Inc. (CLPT) in Q1 2025, acquiring 128,698 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held ClearPoint Neuro, Inc. (CLPT) for 4 quarters since Q1 2025.
Paul Tudor Jones's largest addition to ClearPoint Neuro, Inc. (CLPT) was in Q1 2026, adding 156,971 shares worth $1.43 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 156,971 shares of ClearPoint Neuro, Inc. (CLPT), valued at approximately $1.43 M.
As of the Q1 2026 filing, ClearPoint Neuro, Inc. (CLPT) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in ClearPoint Neuro, Inc. (CLPT) was 156,971 shares, as reported at the end of Q1 2026.